Manufacturer
Janssen Products
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 28
- Molecules
- 10
- Therapy areas
- 4
Janssen Products is a pharmaceutical manufacturer based in United States. MedsAcross lists 28 of its products across 10 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Janssen Products LP, Janssen Products, LP
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Janssen Products products through licensed channels, with the documents your regulator needs.
Oncology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Balversa 3 mg tabletOral | Erdafitinib | US FDA | Available on request |
| Balversa 4 mg tabletOral | Erdafitinib | US FDA | Available on request |
| Balversa 5 mg tabletOral | Erdafitinib | US FDA | Available on request |
| Erleada 240 mg tabletOral | Apalutamide | US FDA | Available on request |
| Erleada 60 mg tabletOral | Apalutamide | US FDA | Available on request |
| Yondelis 0.05 mg/mL powder for injectionIntravenous Cold chain | Trabectedin | US FDA | Available on request |
HIV
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Edurant 25 mg tabletOral | Rilpivirine | US FDA | Available on request |
| Edurant Ped 2.5 mg tablet for oral suspensionOral | Rilpivirine | US FDA | Available on request |
| Intelence 100 mg tabletOral | Etravirine | US FDA | Available on request |
| Intelence 200 mg tabletOral | Etravirine | US FDA | Available on request |
| Intelence 25 mg tabletOral | Etravirine | US FDA | Available on request |
| Symtuza 150 mg/800 mg/200 mg/10 mg tabletOral | Cobicistat, Darunavir, Emtricitabine and Tenofovir alafenamide | US FDA | Available on request |
Haematology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Procrit 10000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Procrit 2000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Procrit 20000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Procrit 3000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Procrit 4000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Procrit 40000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
Tuberculosis
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Sirturo 100 mg tabletOral | Bedaquiline | US FDA | Available on request |
| Sirturo 20 mg tabletOral | Bedaquiline | US FDA | Available on request |
Other products
8 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Prezcobix 150 mg/675 mg tabletOral | Cobicistat and Darunavir ethanolate | US FDA | Available on request |
| Prezcobix 150 mg/800 mg tabletOral | Cobicistat and Darunavir ethanolate | US FDA | Available on request |
| Prezcobix Ped 90 mg/600 mg tablet for oral suspensionOral | Cobicistat and Darunavir ethanolate | US FDA | Available on request |
| Prezista 100 mg/mL oral suspensionOral | Darunavir ethanolate | US FDA | Available on request |
| Prezista 150 mg tabletOral | Darunavir ethanolate | US FDA | Available on request |
| Prezista 600 mg tabletOral | Darunavir ethanolate | US FDA | Available on request |
| Prezista 75 mg tabletOral | Darunavir ethanolate | US FDA | Available on request |
| Prezista 800 mg tabletOral | Darunavir ethanolate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Janssen Products
Send a request for any of these products. We confirm the licensed source, documents and lead time.